CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
-25.6%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$585M
AUM Growth
-$230M
(-28%)
Cap. Flow
-$14.9M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
58.39%
Holding
39
New
3
Increased
9
Reduced
8
Closed
6
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
+$12M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$7.14M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$6.46M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$6.2M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$5.79M |
Top Sells
| 1 |
Sangamo Therapeutics
SGMO
|
+$10.6M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$9.76M |
| 3 |
OraSure Technologies
OSUR
|
+$8.11M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$6.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$6.21M |
Sector Composition
| 1 | Healthcare | 85.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $50.4M | 8.63% |
360,000
| – | – |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38.6M | 6.6% |
790,000
-15,000
| -2% | -$733K |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $34.5M | 5.9% |
640,000
-110,000
| -15% | -$5.93M |
|
4
Codexis
CDXS
$224M
| $33.8M | 5.79% |
2,025,000
| – | – |
|
|
ONCE
5
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $32.9M | 5.62% |
840,000
+165,000
| +24% | +$6.46M |
|
|
BLUE
6
DELISTED
bluebird bio
BLUE
| $32.7M | 5.6% |
25,476
+5,558
| +28% | +$7.14M |
|
7
Fate Therapeutics
FATE
$111M
| $32.7M | 5.6% |
2,550,000
| – | – |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $29.9M | 5.11% |
312,000
| – | – |
|
9
BioLife Solutions
BLFS
$1.24B
| $29.2M | 5% |
2,428,571
| – | – |
|
|
NVTA
10
DELISTED
Invitae Corporation
NVTA
| $26.5M | 4.54% |
2,400,000
| – | – |
|
|
11
Alnylam Pharmaceuticals
ALNY
$60.2B
| $25.9M | 4.43% |
355,000
+85,000
| +31% | +$6.2M |
|
|
12
Agios Pharmaceuticals
AGIO
$2.13B
| $20.5M | 3.51% |
445,000
-134,776
| -23% | -$6.21M |
|
|
GNMK
13
DELISTED
GenMark Diagnostics, Inc
GNMK
| $18.5M | 3.17% |
3,815,000
+315,000
| +9% | +$1.53M |
|
|
BOLD
14
DELISTED
Audentes Therapeutics, Inc
BOLD
| $18.3M | 3.14% |
860,000
+235,000
| +38% | +$5.01M |
|
15
Illumina
ILMN
$15.5B
| $18M | 3.08% |
61,680
-11,822
| -16% | -$3.45M |
|
|
16
Sarepta Therapeutics
SRPT
$1.89B
| $16.4M | 2.8% |
150,000
+110,000
| +275% | +$12M |
|
17
Dianthus Therapeutics
DNTH
$1.5B
| $15.1M | 2.58% |
165,207
+24,531
| +17% | +$2.24M |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.4M | 2.46% |
350,000
-90,000
| -20% | -$3.69M |
|
|
19
Sangamo Therapeutics
SGMO
$157M
| $12.4M | 2.12% |
1,080,000
-920,000
| -46% | -$10.6M |
|
|
GRTS
20
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $11.1M | 1.9% |
720,586
| – | – |
|
21
Evolent Health
EVH
$1.03B
| $11M | 1.88% |
550,000
| – | – |
|
22
Editas Medicine
EDIT
$254M
| $10.9M | 1.87% |
480,000
+20,000
| +4% | +$455K |
|
23
Voyager Therapeutics
VYGR
$245M
| $10.6M | 1.81% |
1,128,075
-6,925
| -0.6% | -$65.1K |
|
|
ONC
24
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.9B
| $9.82M | 1.68% |
70,000
| – | – |
|
25
Q32 Bio
QTTB
$23.2M
| $7.83M | 1.34% |
19,444
| – | – |
|